Knight Therapeutics Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	413.85	371.3	328.2	293.56	243.48	199.52
Revenue Growth (YoY)	18.70%	13.13%	11.80%	20.57%	22.03%	320.38%
Cost of Revenue	237.99	196.9	175.55	155.5	128.07	117.83
Gross Profit	175.86	174.41	152.65	138.06	115.41	81.69
Selling, General & Admin	113.97	99.35	83.69	88.62	74.38	74.43
Depreciation & Amortization Expenses	46.28	44.36	45.04	51.74	41.18	26.19
Research & Development	27.13	23.3	17.55	14.76	12.69	11.73
Other Operating Expenses	-	-	9.26	23.98	-	-
Operating Income	-11.52	7.4	-2.89	-41.04	-12.83	-30.66
Interest Income	7.65	10.41	12.58	10.63	7.38	14.32
Interest Expense	-8.95	-9.22	-12.49	-6.6	-3.62	-3.4
Other Non-Operating Income (Expense)	2.77	-6.53	-19.19	-6.95	15.76	51.82
Total Non-Operating Income (Expense)	1.47	-5.35	-19.1	-2.92	19.52	62.74
Pretax Income	-10.05	2.05	-21.99	-43.96	6.69	32.09
Provision for Income Taxes	-5.09	0	0	0	0	0.65
Net Income	-4.96	2.05	-21.99	-43.96	6.69	41.74
Minority Interest in Earnings	-	-	-	-	-	-10.31
Net Income to Common	-4.96	2.05	-21.99	-43.96	6.69	41.74
Net Income Growth	-	-	-	-	-83.97%	327.33%
Shares Outstanding (Basic)	100	101	107	115	124	132
Shares Outstanding (Diluted)	100	101	107	115	125	132
Shares Change (YoY)	-1.73%	-5.61%	-6.46%	-7.74%	-5.66%	-5.82%
EPS (Basic)	-0.04	0.04	-0.16	-0.26	0.13	0.32
EPS (Diluted)	-0.04	0.04	-0.16	-0.26	0.13	0.32
EPS Growth	-	-	-	-	-59.38%	220.00%
Free Cash Flow	33.59	33.81	34.99	42.12	40.79	-17.58
Free Cash Flow Growth	-0.65%	-3.37%	-16.92%	3.26%	-	-
Free Cash Flow Per Share	0.34	0.33	0.33	0.37	0.33	-0.13
Gross Margin	42.49%	46.97%	46.51%	47.03%	47.40%	40.94%
Operating Margin	-2.78%	1.99%	-0.88%	-13.98%	-5.27%	-15.36%
Profit Margin	-0.55%	0.55%	-6.70%	-14.97%	2.75%	15.76%
FCF Margin	8.12%	9.11%	10.66%	14.35%	16.75%	-8.81%
EBITDA	43.94	60.51	47.51	21.58	35.08	1.42
EBITDA Margin	10.62%	16.30%	14.48%	7.35%	14.41%	0.71%
EBIT	-11.52	7.4	-2.89	-41.04	-12.83	-30.66
EBIT Margin	-2.78%	1.99%	-0.88%	-13.98%	-5.27%	-15.36%
Effective Tax Rate	49.51%	0.00%	0.00%	0.00%	0.00%	2.03%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.